• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Air Embolism (1697); Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914); Hypoxia (1918); Respiratory Failure (2484); Asystole (4442)
Event Date 09/27/2023
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported an air embolism occurred.During a watchman left atrial appendage closure (laac) procedure, a versacross connect kit and watchman access sheath was selected for use.After the transseptal puncture (tsp) was completed and versacross devices were removed, the patient became hypotensive and atropine was administered.It was observed the hemostasis valve on the watchman sheath was not completely closed and an air embolism occurred in the left atrium.The physician believes, an air entered via sheath which was in left atrium while patient was asleep and heavily breathing before it was closed down tightly.Air was not visualized on intracardiac echocardiography (ice) or fluoroscopy.The patient noted without a pulse (asystole); cardiopulmonary resuscitation (cpr) and rapid pacing were performed and the patient was intubated.After five to seven minutes, the patient regained pulse.The procedure was completed with the successful implantation of the closure device.The patient remained hospitalized and intubated due to acute hypoxic respiratory failure.The device is not expected to be returned for analysis.It was further confirmed, the patient is in palliative care.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal, qc H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18005193
MDR Text Key326516767
Report Number2124215-2023-59009
Device Sequence Number1
Product Code DRE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/27/2023
Initial Date FDA Received10/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Life Threatening;
Patient Age76 YR
Patient SexMale
-
-